Everolimus-Eluting Versus Sirolimus-Eluting Stents
نویسندگان
چکیده
منابع مشابه
Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET) Running title: Kimura et al.; Everolimus-eluting versus Sirolimus-eluting stents
Takeshi Kimura, MD; Takeshi Morimoto, MD; Masahiro Natsuaki, MD; Hiroki Shiomi, MD; Keiichi Igarashi, MD; Kazushige Kadota, MD; Kengo Tanabe, MD; Yoshihiro Morino, MD; Takashi Akasaka, MD; Yoshiki Takatsu, MD; Hideo Nishikawa, MD; Yoshito Yamamoto, MD; Yoshihisa Nakagawa, MD; Yasuhiko Hayashi, MD; Masashi Iwabuchi, MD; Hisashi Umeda, MD; Kazuya Kawai, MD; Hisayuki Okada, MD; Kazuo Kimura, MD; C...
متن کاملInterventional Cardiology Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)
Background—Several recent randomized trials comparing everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) reported similar outcomes. However, only 1 trial was powered for a clinical end point, and no trial was powered for evaluating target-lesion revascularization. Methods and Results—Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial is a prospective ...
متن کاملEverolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials.
BACKGROUND The aim of the study was to compare the outcomes after placement of the everolimus-eluting stent (EES; Xience V) and the sirolimus-eluting stent (SES; Cypher) in patients with coronary artery disease. The second-generation EES is currently one of the most commonly used drug-eluting stents in clinical practice. Although it has clearly been shown superior to paclitaxel-eluting stents, ...
متن کاملEverolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
Kyung Woo Park, MD,* In-Ho Chae, MD,† Do-Sun Lim, MD,‡ Kyoo-Rok Han, MD,§ Han-Mo Yang, MD,* Hae-Young Lee, MD,* Hyun-Jae Kang, MD,* Bon-Kwon Koo, MD,* Taehoon Ahn, MD, Jung-Han Yoon, MD,¶ Myung-Ho Jeong, MD,# Taek-Jong Hong, MD,** Woo-Young Chung, MD,†† Sang-Ho Jo, MD,‡‡ Young-Jin Choi, MD,‡‡ Seung-Ho Hur, MD,§§ Hyuck-Moon Kwon, MD, Dong-Woon Jeon, MD,¶¶ Byung-Ok Kim, MD,## Si-Hoon Park, MD,***...
متن کاملPaclitaxel-Eluting Versus Sirolimus-Eluting Stents in Diabetes Mellitus
Background—Diabetes is a powerful predictor of adverse events in patients undergoing percutaneous coronary intervention. Drug-eluting stents reduce restenosis rates compared with bare metal stents; however, controversy remains regarding which drug-eluting stents provides greater benefit in patients with diabetes. Accordingly, we compared the safety and efficacy of sirolimus-eluting stents (SES)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Cardiovascular Interventions
سال: 2011
ISSN: 1941-7640,1941-7632
DOI: 10.1161/circinterventions.111.963256